Results 161 to 170 of about 43,943 (196)

Psychotropic Drugs in Internal Medicine.

Archives of Internal Medicine, 1970
The Excerpta Medica Foundation has taken on the task of publishing complete proceedings from various international congresses. The present volume is 182 in this series. This symposium was held in May 1968, so that publication delay has been no more than usual. The resulting product is a slim, slick book which commands a high price for its size.
openaire   +2 more sources

Use of psychotropic medicines in mental health care

2018
Introduction This chapter provides an overview of the common medicines prescribed within mental health care and explores the ways in which personal narratives and social expectations can influence the experience of taking medicines.
Mark Loughhead, Simon Bell, Nicholas Procter   +2 more
openaire   +3 more sources

The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines

The Lancet Child & Adolescent Health, 2023
[no abstract available]
Papola, Davide, Ostuzzi, Giovanni, Gastaldon, Chiara, Barbui, Corrado   +3 more
openaire   +2 more sources

Psychotropics in Your Medicine Cabinet: A Case Study of Dimenhydrinate Use

Journal of Addiction Medicine, 2019
Reporting of intoxication and withdrawal from aberrant use of over-the-counter medication has been sparse and inconsistent in literature. Attributed to their anticholinergic properties, medications such as dimenhydrinate (Gravol) taken in supratherapeutic doses have been associated with euphoria, anxiolysis, and hallucinations.
Francesca Di Paola, Nitin Chopra, Xia Wen   +2 more
openaire   +2 more sources

Geriatric Psychotropic Stewardship Team to de‐escalate inappropriate psychotropic medications in general medicine inpatients: An evaluation

Australasian Journal on Ageing, 2018
ObjectivesTo assess the feasibility and effectiveness of a Geriatric Psychotropic Stewardship Team (GPST) and to achieve inpatient de‐escalation of inappropriate psychotropic medications in patients aged over 65 years on a general medicine ward.MethodsA multidisciplinary GPST conducted twice‐weekly rounds on general medicine inpatients known to be ...
Olivia A Pellicano, Erica Tong, Gary Yip, Louise Monk, Xiang Loh, Michelle Ananda‐Rajah, Michael Dooley   +6 more
openaire   +2 more sources

Psychotropic Drugs Reemerging as Headache Medicines

CNS Drugs
Scientific and public attention on the therapeutic effects of psychedelics and other psychoactive compounds in headache disorders has recently grown. The use and reported therapeutic effects of such treatments have long been reported, though formal clinical trials are only recently taking place.
openaire   +2 more sources

Mothers' Psychotropic Medicine Use and Children's Abusable Substance Use

Journal of Pharmaceutical Marketing & Management, 1994
(1994). Mothers' Psychotropic Medicine Use and Children's Abusable Substance Use. Journal of Pharmaceutical Marketing & Management: Vol. 9, No. 1, pp. 91-97.
Mary Ann D'Elio, Ronald J. Iannotti, Patricia J. Bush, Terri Smith Moore   +3 more
openaire   +2 more sources

Psychotropic medication—insights from evolutionary medicine

2015
The therapeutic options for psychiatric disorders have been dramatically advanced by the development of medication for almost all conditions. However, personalized treatment approaches need to carefully consider costs (potential harm) and benefits. All psychotropic drugs have side-effects in relevant areas of life, including social play (stimulants ...
openaire   +1 more source

Clinical management of metastatic colorectal cancer in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2022
Fortunato Ciardiello, Fortunato Ciardiello, Davide Ciardiello   +2 more
exaly  

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Paulo Cáceres Guido, Jun J Mao, Lorenzo Cohen   +2 more
exaly